SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laserscope (NASDAQ LSCP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: geoffrey Wren who wrote (156)11/5/1997 4:23:00 PM
From: David K.  Read Replies (1) of 314
 
Thanks Geoff for your comments. Obviously, the future is not clear
saling, but I believe that have potential. On the fundamental side, they have a book value of about $2.50 per share, sales of about
$5 per share, a .06 debt to equity ratio, and increasing annual revenues since 95. Their products as well as their research seems be effective and their international expansion is well-timed. If everything was top-notch, the stock price would be in the 20's. One other factor that gives me a modicum of optimism is the lack of insider selling (let's hope this doesn't appear).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News